Brez(R), the First Over-the-Counter, Intranasal Breathing Aid Clinically Proven to Reduce Primary Snoring, Debuts in Rite Aid Pharmacies
Data Show Significant Reduction In Snoring Events, Increase in Sleep Quality For Bed Partner
SCOTTSDALE, Ariz., Jan. 28 /PRNewswire/ -- AirWare, Inc., maker of Brez premium nasal breathing aids, the first commercially available device for inside the nose clinically proven to reduce snoring an...
New intranasal influenza vaccine triggers robust immunity with significantly less antigen
Washington, DC (October 26, 2008) A single administration of a novel, nasally delivered influenza vaccine elicited immune responses in ferrets that were more than 20 times higher than those generated by two injections of the currently approved vaccines, according to a study by NanoBio Corporation....
Nanoemulsion-Based Intranasal Influenza Vaccine Adjuvant Triggers Robust Immunity Using Significantly Less Antigen
Data presented at the 2008 ICAAC/IDSA meeting in Washington, DC
WASHINGTON, Oct. 27 /PRNewswire/ -- A single administration of a novel,
nasally delivered influenza vaccine elicited immune responses in ferrets
that were more than 20 times higher than those generated by two injections
CDC To Conduct Pre-clinical Trails Of BioDiem's Intranasal Bird Flu Vaccine
The US-based Center for Disease Control and Prevention (CDC) has signed a two-year cooperative deal with Melbourne-based pharmaceutical development company//, BioDiem, to conduct pre-clinical trials on a candidate vaccine developed by BioDiem and its Dutch partner Akzo Nobels Nobilon.
The CDC ...
Cystic Fibrosis Treatment May Cause Hearing Loss
...ave regular hearing tests that specifically assess sensorineural hearing loss, especially when patients have undergone repeated courses of systemic or intranasal
aminoglycoside treatments, the researchers concluded.
The study appears in the July issue of the journal Otolaryngology--Head and Neck Surgery .
Lupin Expands Branded Play
The U.S. Food and Drug Administration (FDA) has already approved AllerNaze(TM) (triamcinolone acetonide, USP) Nasal Spray, 50 mcg, an aqueous based intranasal
steroid indicated for the once daily treatment of nasal symptoms associated with both seasonal allergic rhinitis (SAR) and perennial allergic rhinitis...
Homeopathic Pharmacists' Association Highlights the Extraordinary Safety Record of Homeopathic Medicines
... Matrixx Innovations, Inc., in connection with that company's sale of Zicam intranasal
zinc medications. According to the FDA, these intranasal
zinc products have been associated with a number of cases of loss of smell....
Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel
...request a refund.
Since Zicam Cold Remedy intranasal
Cold Remedy products were first introduced in the ...demonstrated both the safety and efficacy of Zicam intranasal
cold remedy products under conditions of ordinary ...re is no causal link between its Zicam Cold Remedy intranasal
gel products and anosmia," said William J. Hemelt,...
Perfect Father's Day Gift: The Sound of Silence
...armacies and online.
About AirWare, Inc.
AirWare, Inc., founded in 2008, develops, manufactures, and markets Brez(R), a premium, ergonomic, intranasal
breathing aid. Brez is a patented anti-snoring solution clinically proven to significantly reduce snoring, made without drugs, latex or adhesives. B...
Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18
...aken place at the meeting.
May 18, 2009; 12:30 PM to 2:00 PM PDT / 3:30 PM to 5 PM EDT
Pharmacokinetics of intranasal
Versus Oral Administration of Lisdexamfetamine Dimesylate in Healthy Adults
Poster Presentation #NR2-027
May 18, 2009; 12:30 PM to 2:00 PM PDT...
Intranasal in Medical Technology
Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
BOXMEER, Netherlands, March 13 /PRNewswire-FirstCall/ -- Nobilon, the human vaccine business unit of Schering-Plough Corporation (NYSE: SGP ), today announced that it has reached an important milestone with the initiation of its first-in-human clinical development program for SCH 900795, a new...
Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
READING, England, February 26 /PRNewswire/ --
Apomorphine for the Treatment of Motor Fluctuations in
Advanced Parkinson's Disease
Diazepam for the Treatment of Acute Repetitive Seizures in
- Phase II Trials on Both Projects to be Initiate...
Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU
VIENNA, Austria, July 8 /PRNewswire/ -- Avir Green Hills Biotechnology
starts a clinical phase I study with its intranasal
against pandemic influenza. This novel generation of a live-attenuated
vaccine based on the deletion of the NS1 gene has shown superior
preclinical data. ...
ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
Top-line Data Show Significant Improvements With ROX-828 In Migraine Pain And Related Symptoms For Up to 48 Hours Vs. Placebo
MENLO PARK, Calif., April 28 /PRNewswire/ -- ROXRO PHARMA, Inc. today
announced positive top-line data from a clinical study of the company's
Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well
Tolerated in Phase 3 Study
Patients Using ROX-888 Required Significantly Less Morphine After
Major Abdominal Surgery Company On Track To File NDA In 2008
MENLO PARK, CA (June 6, 2007) – ROXRO
PHARMA Inc. said today that ROX-888, its novel intranasal
analgesic, rapidly and effectively eased pain and was well
Trial Results with Intranasal Fentanyl Hold Promise for Treatment
of Breakthrough Pain in Cancer
BUDAPEST, Hungary, June, 7, 2007--A pioneering nasal spray
could stop thousands of patients with cancer from suffering
unnecessary pain; it was reported today1 at the 10th Congress of
the European Association for Palliative Ca...
Bentley Reports Positive Results with Nasulin Intranasal Insulin
Spray at the American Diabetes Association Meeting
EXETER, N.H.--(BUSINESS WIRE)--Jun 25, 2007 - Bentley
Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical
company, today announced positive clinical results in three
Company-sponsored studies of its investigational drug, Nasulin(TM),
insulin spray. The data were presented th...
VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
...he treatment of cancer, respiratory and inflammatory diseases, announced today that it has initiated a Phase I clinical trial of VTX-1463, a selective intranasal
TLR8 agonist for the treatment of allergic rhinitis. The objectives of this trial will be to assess safety, tolerability and pharmacokinetics of singl...
Michael J. Fox Foundation Awards $2.1 Million to Improve Drug Delivery in Parkinson's Disease
...vel Antibodies for the Delivery of Parkinson's Therapeutics
Eric Shusta, Ph.D., and Clive Svendson, Ph.D., University of Wisconsin, Madison
Gene Therapy: Next Steps
Barbara Lee Waszczak, Ph.D., Northeastern University
About The Michael J. Fox Foundation
The Michael J. Fox Fo...
Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis
...'s lead product candidates are treatments for herpes
labialis (cold sores), onychomycosis (nail fungus), acne and cystic fibrosis
and a broad range of intranasal
vaccines. The company's headquarters and
laboratory facilities are located in Ann Arbor, Mich. ...
Intranasal in Medical Products
Storz Intranasal Antrum Punch
Description: 4 mm x 4 mm downward biting jaws, curved right, length of shaft 115 mm, overall length 9.3 inches....
Company:Bausch & Lomb Storz
Intranasal in Medical Dictionary
... patients receive general anesthesia before septoplasty . ... Septoplasty . Normal anatomy. The septum is the cartilage and bony ... Other intranasal
surgery indicating septoplasty includes polypectomy (removal of ... Cosmetic, Plastic and Reconstructive Surgery, Cosmetic Laser and Dermatolo...
... Encyclopedia article of Lobar pneumonia at Reference.com compiled from comprehensive and current sources. ... of lobar pneumonia following intranasal
... Tuberculous primary lobar pneumonia can occur in any lobe or segment of lung. ... E Right lower lobar pneumonia . ... Any lobar ...
Intranasal in Biological News
Tips from the journals of the American Society for Microbiology
...tening pandemic potential," say the researchers.
(L.A. Perrone, A. Ahmad, V. Veguilla, X. Lu, G. Smith, J. M. Katz, P. Pushko, T.M. Tumpey. 2009. intranasal
vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. Journal of Virol...
Yale scientists show that a microRNA can reduce lung cancer growth
...monstrates that let-7 inhibits the growth of lung cancer cells in culture and in lung tumors in mice. They also showed that let-7 can be applied as an intranasal
drug to reduce tumor formation in a RAS mouse model lung cancer.
We believe that our studies provide the first direct evidence in mammals, that le...
SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal-induced inflamma
...al Phase 3 clinical trial for its lead pharmaceutical product, SinuNase, an intranasal
formulation of the antifungal amphotericin B 0.01% suspension. In order to...pany, this is the first and only Phase 3 clinical trial for CS and the only intranasal
antifungal that has been submitted to the FDA as an Investigative New Drug ...
Tips from the Journals of the American Society for Microbiology
...ction in lethality and highly increased cellular and humoral immune responses. Additionally, mice vaccinated with Wyeth IL-15 fully survived a lethal intranasal
challenge ten months after vaccination. The second candidate MVA IL-15 also demonstrated greater immunogenicity and efficacy than Dryvax.
Intranasal in Biological Technology
Evoke Pharma, Inc. Initiates Phase 2b Metoclopramide Intranasal Trial (MINT) in Patients With Diabetic Gastroparesis
SAN DIEGO, May 5 /PRNewswire/ -- - Evoke Pharma, Inc., a privately-held specialty pharmaceutical company, announced today that it has initiated a Phase 2b clinical trial to evaluate EVK-001 for the treatment of adults with symptoms of diabetic gastroparesis. Gastroparesis is a syndrome characteriz...
FluMist(R) Begins Shipping for 2009-2010 Influenza Season
...certain types of influenza disease in children, adolescents and adults 2-49 years of age. FluMist may not protect everyone who gets it. FluMist is for intranasal
Who may not be able to get FluMist?
FluMist is not right for everyone. FluMist must not be given to: people with histo...
HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)
...s F in children two to six years of age, and sore throat in adults.
FluMist may not protect all individuals receiving the vaccine. FluMist is for intranasal
Please see complete Prescribing Information for FluMist, call 1-877-FLUMIST (1-877-358-6478) or visit http://www.flumist.co...
NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains
...sed to a lethal dose of the 1918 influenza virus, regardless of the route by which the vaccine was administered. Remarkably, animals immunized by the intranasal
route were also protected against a lethal dose of a contemporary, highly pathogenic avian influenza subtype H5N1 virus strain, isolated from a fatal ...
Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries
...tute of Experimental Medicine in St. Petersburg, Russian Federation. The LAIV may offer several improvements over current vaccines such as single-dose intranasal
spray delivery, improved convenience and earlier and broader protection, which is of particular interest in a pandemic situation. Nobilon is developin...
NanoBio Corporation Raises $12 Million in Series B Financing
...atological products, anti-infective
treatments and intranasal
vaccines, announced today that it has acquired $12...ng that a single administration of NanoBio's
influenza vaccine elicits immune responses in ferr...atological products, anti-infective
treatments and intranasal
vaccines derived from its patented NanoStat(TM)
Jazz Pharmaceuticals Announces Reduction in Force to Reflect Streamlined Operations
... positive top-line results from the first of two pivotal
Phase III clinical trials of JZP-6. JZP-8, Jazz Pharmaceuticals' product
candidate providing intranasal
delivery of clonazepam for the treatment of
acute repetitive seizures, is continuing its Phase II clinical trial.
"Concentrating our company's...
NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate
... increased with higher VLP doses.
Subsets of mice that had been immunized with either RSV VLPs via
intraperitoneal inoculation or live RSV via intranasal
inoculation received a
vaccine booster dose and were challenged with live RSV intra-nasally.
Unimmunized mice were evaluated as controls. The VLP-imm...
Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients
...ring from allergic
rhinitis. MRX-4 was given as an intranasal
The Nasal Allergen Challenge ...RX-4 was compared
with both placebo (Arm 1) and an intranasal
steroid Rhinocort(R) (as a
positive control, Arm 2...1 of the study consisted of a six-day,
administration of placebo or MRX-4 followed by an
SoluBest Appoints Michael Sheckler, MBA, as CEO
...opportunities in the U.S., and
developing and implementing the launch and marketing plans for new
Upon leaving Bespak, Mr. Sheckler joined intranasal
Technology, Inc, a
Kentucky-based nasal drug delivery company as Director of Business
Development where he successfully created and implemented a busi...